Logo image of ALSEN.PA

SENSORION SA (ALSEN.PA) Stock Fundamental Analysis

Europe - EPA:ALSEN - FR0012596468 - Common Stock

0.354 EUR
-0.01 (-3.28%)
Last: 10/28/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ALSEN scores 3 out of 10 in our fundamental rating. ALSEN was compared to 73 industry peers in the Biotechnology industry. The financial health of ALSEN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ALSEN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALSEN had negative earnings in the past year.
In the past year ALSEN has reported a negative cash flow from operations.
ALSEN had negative earnings in each of the past 5 years.
ALSEN had a negative operating cash flow in each of the past 5 years.
ALSEN.PA Yearly Net Income VS EBIT VS OCF VS FCFALSEN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -38.30%, ALSEN is in line with its industry, outperforming 42.47% of the companies in the same industry.
With a Return On Equity value of -49.29%, ALSEN perfoms like the industry average, outperforming 57.53% of the companies in the same industry.
Industry RankSector Rank
ROA -38.3%
ROE -49.29%
ROIC N/A
ROA(3y)-45.38%
ROA(5y)-34.99%
ROE(3y)-69.45%
ROE(5y)-51.62%
ROIC(3y)N/A
ROIC(5y)N/A
ALSEN.PA Yearly ROA, ROE, ROICALSEN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

ALSEN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSEN.PA Yearly Profit, Operating, Gross MarginsALSEN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

ALSEN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALSEN has more shares outstanding
ALSEN has a better debt/assets ratio than last year.
ALSEN.PA Yearly Shares OutstandingALSEN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALSEN.PA Yearly Total Debt VS Total AssetsALSEN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.46 indicates that ALSEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.46, ALSEN is doing good in the industry, outperforming 69.86% of the companies in the same industry.
ALSEN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ALSEN has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. ALSEN outperforms 82.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.46
ROIC/WACCN/A
WACCN/A
ALSEN.PA Yearly LT Debt VS Equity VS FCFALSEN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 4.90 indicates that ALSEN has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.90, ALSEN is doing good in the industry, outperforming 79.45% of the companies in the same industry.
ALSEN has a Quick Ratio of 4.90. This indicates that ALSEN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.90, ALSEN belongs to the best of the industry, outperforming 82.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.9
Quick Ratio 4.9
ALSEN.PA Yearly Current Assets VS Current LiabilitesALSEN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

ALSEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.25%, which is quite good.
EPS 1Y (TTM)11.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 42.16% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALSEN will show a very strong growth in Revenue. The Revenue will grow by 68.59% on average per year.
EPS Next Y8.33%
EPS Next 2Y24.72%
EPS Next 3Y14.47%
EPS Next 5Y42.16%
Revenue Next Year17.4%
Revenue Next 2Y36.53%
Revenue Next 3Y15.46%
Revenue Next 5Y68.59%

3.3 Evolution

ALSEN.PA Yearly Revenue VS EstimatesALSEN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
ALSEN.PA Yearly EPS VS EstimatesALSEN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALSEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSEN.PA Price Earnings VS Forward Price EarningsALSEN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSEN.PA Per share dataALSEN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

ALSEN's earnings are expected to grow with 14.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.72%
EPS Next 3Y14.47%

More info and screens

0

5. Dividend

5.1 Amount

ALSEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENSORION SA

EPA:ALSEN (10/28/2025, 7:00:00 PM)

0.354

-0.01 (-3.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-17 2025-09-17
Earnings (Next)03-12 2026-03-12/amc
Inst Owners53.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap106.43M
Revenue(TTM)N/A
Net Income(TTM)-28085000
Analysts86.15
Price Target2.35 (563.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.52%
PT rev (3m)22.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-39.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.87
P/tB 1.9
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.3%
ROE -49.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.38%
ROA(5y)-34.99%
ROE(3y)-69.45%
ROE(5y)-51.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -371.23%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.9
Quick Ratio 4.9
Altman-Z 2.46
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)191.05%
Cap/Depr(5y)144.18%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.33%
EPS Next Y8.33%
EPS Next 2Y24.72%
EPS Next 3Y14.47%
EPS Next 5Y42.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year17.4%
Revenue Next 2Y36.53%
Revenue Next 3Y15.46%
Revenue Next 5Y68.59%
EBIT growth 1Y-19.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.76%
EBIT Next 3Y13.96%
EBIT Next 5Y38.57%
FCF growth 1Y-24.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.13%
OCF growth 3YN/A
OCF growth 5YN/A

SENSORION SA / ALSEN.PA FAQ

What is the ChartMill fundamental rating of SENSORION SA (ALSEN.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSEN.PA.


What is the valuation status for ALSEN stock?

ChartMill assigns a valuation rating of 0 / 10 to SENSORION SA (ALSEN.PA). This can be considered as Overvalued.


Can you provide the profitability details for SENSORION SA?

SENSORION SA (ALSEN.PA) has a profitability rating of 1 / 10.